iView Therapeutics

Cranbury, NJ · Founded 2015 · Privately Held (backing)

Developer of topical drugs designed for applications in ophthalmology, dermatology, and otolaryngology. iView Therapeutics is based in Cranbury, NJ and was founded in 2015. It was valued at $107 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $39.2 million across 2 recorded rounds; the latest was a $9.2 million early-stage round in May 2024.

PMV mark · valuation
$107.4M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$39.2M
Last round
Early Stage VC
May 2024
How much has iView Therapeutics raised?
$39.2Macross 2 recorded rounds · Feb 2021 – May 2024

Most recently, iView Therapeutics raised $9.2M in its Early Stage VC (May 2024).

Free account
More of iView Therapeutics with a free account
  • ·The complete investor list: 16 names
  • ·Watch iView Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

iView Therapeutics round by round

2 rounds
May 2024Early Stage VC$9.2MSEC filing▮
5 investors participated
Feb 2021Early Stage VC$30.0MSEC filing▮
15 investors participated

How much has iView Therapeutics raised?

iView Therapeutics has raised $39.2 million across 2 recorded rounds since 2021. The largest was a $9.2 million early-stage round in May 2024.

iView Therapeutics has filed 4 Form Ds with the SEC since 2022, most recently in Jun 2025 ($9.2 million sold to 5 investors).

iView Therapeutics investors

16 investors are on record for iView Therapeutics, including Cowin Capital, Proxima Ventures (China), BioAdvance Capital (Conshohocken) and Alpha Bioventure. The early-stage round in May 2024 drew 5 investors.

For fundraisers
Raising for a company like iView Therapeutics?

16 investors have backed iView Therapeutics.

See all 16 investors →

Frequently asked about iView Therapeutics

How much has iView Therapeutics raised?
iView Therapeutics has raised $39.2M in total across 2 recorded funding rounds.
When was iView Therapeutics's last funding round?
iView Therapeutics's most recent recorded round was Early Stage VC in May 2024, raising $9.2M.